Annovis Bio, Inc.
ANVS · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Hoffman Michael B: Form 4
Insider disclosure · Filed · Report period 06 Nov 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form SCHEDULE 13G
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ANVS · 03615A108 - Common Stock, $0.0001 par value per share
Company details and SEC sources
CIK 0001477845 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ANVS on NYSE
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 101 Lindenwood Drive, Suite 225, Malvern, PA, 19355
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- QR Pharma, Inc. (to 15 Mar 2019)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields